SyntheticMR
Ulrik Harrysson has extensive work experience in sales and marketing roles. Ulrik is currently the CEO of SyntheticMR since July 2019. Ulrik also served as a Board Member at Qlife from May 2021 to April 2023. Previously, they held senior leadership positions at Hermes Medical Solutions, including Senior Vice President Global Marketing and Sales from January 2019 to June 2019, and Vice President Sales from April 2018 to December 2018. Prior to that, Ulrik worked at HemoCue AB, where they held various sales director and managerial positions from 2006 until 2018. Ulrik started their career at Pfizer as a Sales Manager from October 2000 to January 2006 and earlier worked as a Sales Manager at Parke-Davis, Division of Warner Lambert Nordic AB from August 1995 to September 2000.
Ulrik Harrysson completed their Master of Science in Business Administration with a focus on Marketing from Jönköping International Business School between 1990 and 1995.
SyntheticMR
SyntheticMR AB develops and markets innovative software solutions for Magnetic Resonance Imaging (MRI) that supports a faster and more precise diagnosis of patients worldwide. Join us for the latest updates on news, events and clinical research involving our products. SyntheticMR’s unique SyMRI technology measures the absolute properties of the brain and delivers adjustable contrast images, automatic biomarker segmentation and quantitative data in a single fast scan. SyMRI is designed to help you save valuable time by reducing scan time, all the while aiding as an objective decision support for diagnosis and patient follow-ups. SyMRI offers a fast and standardized protocol with clinically relevant quantitative data for more robust assessments of patients. SyntheticMR AB is headquartered in Linköping, Sweden with sales representation in the USA, Japan and India. The company was founded in 2007 and is listed on the AktieTorget exchange in Stockholm, Sweden.